Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Evaluation of the antitumour activity of the non-steroidal antioestrogen monohydroxytamoxifen in the DMBA-induced rat mammary carcinoma model.

× No keyword cloud information.

51 in total

Review 1. Effect of SERMs on breast tissue.

Authors: S R Goldstein
Journal: J Endocrinol Invest Date: 1999-09 Impact factor: 4.256

2. Profile of V. Craig Jordan.

Authors: Sujata Gupta
Journal: Proc Natl Acad Sci U S A Date: 2011-11-16 Impact factor: 11.205

Review 3. The estrogen receptor: a logical target for the prevention of breast cancer with antiestrogens.

Authors: D A Tonetti; V C Jordan
Journal: J Mammary Gland Biol Neoplasia Date: 1999-10 Impact factor: 2.673

Review 4. Tamoxifen as the first targeted long-term adjuvant therapy for breast cancer.

Authors: V Craig Jordan
Journal: Endocr Relat Cancer Date: 2014-05-06 Impact factor: 5.678

5. The St. Gallen Prize Lecture 2011: evolution of long-term adjuvant anti-hormone therapy: consequences and opportunities.

Authors: V Craig Jordan; Ifeyinwa Obiorah; Ping Fan; Helen R Kim; Eric Ariazi; Heather Cunliffe; Hiltrud Brauch
Journal: Breast Date: 2011-10 Impact factor: 4.380

Review 6. New insights into the metabolism of tamoxifen and its role in the treatment and prevention of breast cancer.

Authors: V Craig Jordan
Journal: Steroids Date: 2007-07-27 Impact factor: 2.668

Review 7. Exploiting the apoptotic actions of oestrogen to reverse antihormonal drug resistance in oestrogen receptor positive breast cancer patients.

Authors: V Craig Jordan; Joan Lewis-Wambi; Helen Kim; Heather Cunliffe; Eric Ariazi; Catherine G N Sharma; Heather A Shupp; Ramona Swaby
Journal: Breast Date: 2007-08-24 Impact factor: 4.380

Review 8. Laboratory studies to develop general principles for the adjuvant treatment of breast cancer with antiestrogens: problems and potential for future clinical applications.

Authors: V C Jordan
Journal: Breast Cancer Res Treat Date: 1983 Impact factor: 4.872

9. Evidence for the metabolic activation of non-steroidal antioestrogens: a study of structure-activity relationships.

Authors: K E Allen; E R Clark; V C Jordan
Journal: Br J Pharmacol Date: 1980 Impact factor: 8.739

Review 10. Tamoxifen. A reappraisal of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors: M M Buckley; K L Goa
Journal: Drugs Date: 1989-04 Impact factor: 9.546